These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7532651)

  • 1. Truncating the putative membrane association region circumvents the difficulty of expressing hepatitis C virus protein E1 in Escherichia coli.
    Yan BS; Liao LY; Leou K; Chang YC; Syu WJ
    J Virol Methods; 1994 Oct; 49(3):343-51. PubMed ID: 7532651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus.
    Claeys H; Volckaerts A; Mertens W; Liang Z; Fiten P; Opdenakker G
    J Med Virol; 1995 Mar; 45(3):273-81. PubMed ID: 7539833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion and purification of HCV E1 protein forms as glutathione-S-transferase fusion in the baculovirus insect cell system.
    Ciccaglione AR; Marcantonio C; Equestre M; Jones IM; Rapicetta M
    Virus Res; 1998 Jun; 55(2):157-65. PubMed ID: 9725668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and simple purification of a truncated, immunologically reactive GST-HCV core (1-123) fusion protein.
    Seong YR; Lee EK; Choi S; Chon SK; Im DS
    J Virol Methods; 1996 May; 59(1-2):13-21. PubMed ID: 8793826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.
    Liu J; Zhu LX; Kong YY; Li GD; Wang Y
    World J Gastroenterol; 2005 Jan; 11(4):503-7. PubMed ID: 15641134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice.
    Hitomi Y; McDonnell WM; Baker JR; Askari FK
    Viral Immunol; 1995; 8(2):109-19. PubMed ID: 8825296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prokaryotic expression of hepatitis C virus envelope 1 gene and application of the expressed product].
    Gao J; Tao Q; Ma D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):20-3. PubMed ID: 12526296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive core peptides of hepatitis C virus produced in Escherichia coli and in vitro DNA amplification-restricted transcription-translation system.
    Esumi M; Hayashi N; Takahashi H; Shikata T; Moriyama M; Arakawa Y; Eto T; Nishihara T; Nozaki C; Mizuno K
    J Virol Methods; 1996 May; 59(1-2):91-8. PubMed ID: 8793834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatitis C virus hypervariable region 1 and its clinical significance.
    Zhang XX; Zhang SY; Liu J; Lu ZM; Wang Y
    World J Gastroenterol; 2003 May; 9(5):1003-7. PubMed ID: 12717846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokaryotic expression and analysis of the antibody response to a Newcastle isolate of the core gene of hepatitis C.
    Milton ID; Watson JP; Guo K; Carter MJ; Bassendine MF; Toms GL
    J Med Virol; 1995 Mar; 45(3):253-8. PubMed ID: 7539832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HCV E1 protein in baculovirus-infected cells: effects on cell viability and apoptosis induction.
    Ciccaglione AR; Marcantonio C; Costantino A; Equestre M; Rapicetta M
    Intervirology; 2003; 46(2):121-6. PubMed ID: 12684551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of the C-terminal hydrophobic region of HCV E2 protein ectodomain in E. coli.
    Liu J; Kong Y; Zhu L; Wang Y; Li G
    Virus Genes; 2002; 25(1):5-13. PubMed ID: 12206308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.
    Lesniewski RR; Boardway KM; Casey JM; Desai SM; Devare SG; Leung TK; Mushahwar IK
    J Med Virol; 1993 Jun; 40(2):150-6. PubMed ID: 7689636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening.
    Hüssy P; Faust H; Wagner JC; Schmid G; Mous J; Jacobsen H
    J Hepatol; 1997 Jun; 26(6):1179-86. PubMed ID: 9210602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
    Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
    J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial NS4 mosaic antigen of hepatitis C virus.
    Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
    J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.